Global Archive - Wearable Injectors Market Trends, Share and Global Size - 2027

  • Report Code : TIPAR00002677
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 184
Buy Now

The wearable injectors market size is projected to reach US$ 13,880.88 million by 2027 from US$ 5,791.23 million in 2019. It is expected to register a CAGR of 11.6% from 2020 to 2027.

Market Insights and Analyst Perspective:

Wearable injection systems are drug-delivery devices that adhere to the body and automatically deliver set doses to the patient at optimal times. Prefilled syringes and autoinjectors deliver the drugs to patients in less than 20 seconds. However, insulin pumps are expensive and complicated for periodic fixed-volume drug delivery. Wearable injection systems are designed to fill both gaps, enabling comfortable, low-profile delivery of precisely dosed medications over fixed or variable periods. As wearable injection systems have emerged in response to these conditions, so has a new set of challenges regarding device design and testing. The rising prevalence of chronic diseases and new product launches drive the wearable injectors market growth. With the growing pervasiveness of diabetes, the increasing awareness of the disease and the associated treatment using wearable injectors are also fueling the growth of the wearable injectors market.

Additionally, government initiatives provide better and more affordable treatments and favorable reimbursement policies, expected to boost the wearable injectors market growth. Furthermore, the wearable injectors market key players are focusing on strategic initiatives by launching new products to expand their geographic reach and enhance capacities to cater to a large customer base. For instance, in January 2020, Tandem Diabetes Care, Inc. launched its t:slim X2 insulin pump with Control-IQ technology commercially in the U.S. market. The t:slim X2 insulin pump device operates on the Control-IQ technology. It uses CGM values and other variables, such as Insulin on board, to predict sensor glucose levels 30 minutes ahead and regulates insulin delivery accordingly.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Global Archive - Wearable Injectors Market: Strategic Insights

Global Archive - Wearable Injectors Market

  • CAGR (2019 - 2027)
  • Market Size 2019
    US$ 5.79 Billion
  • Market Size 2027
    US$ 13.88 Billion

Market Dynamics


Key Players

  • Amgen, Inc.
  • Medtronic
  • BD
  • Insulet Corporation
  • Gerresheimer AG (Sensile Medical)
  • West Pharmaceutical Services, Inc.
  • Ypsomed AG,
  • Tandem Diabetes Care, Inc.
  • Cequr SA

Regional Overview

  • North America
  • Europe
  • Asia-Pacific
  • South and Central America
  • Middle East and Africa

Market Segmentation

  • On-Body Injectors
  • Off-Body Injectors
  • Diabetes
  • Oncology
  • Cardiovascular Disease
  • Autoimmune Disease
  • Other Applications
End User
  • Hospitals and Clinics
  • Homecare Settings
  • Other End Users
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

Market scope and segmentation:

The “Global wearable injectors market” is a specialized and in-depth study focusing on market trends and growth opportunities. The report aims to provide an overview of the wearable injectors market with detailed market segmentation by type, application, end-user, and geography. Per the report's scope, the wearable injectors market is bifurcated into on-body and off-body injectors by product. Based on applications, the market is differentiated into oncology, diabetes, autoimmune disease, cardiovascular disease, and other applications. The wearable injectors market is segmented into homecare settings, hospitals and clinics, and others based on end-user. The wearable injectors market based on geography is segmented into North America (US, Canada, and Mexico), Europe (Germany, France, Italy, U.K., and Rest of Europe), Asia Pacific (Australia, China, Japan, India, South Korea, and Rest of Asia Pacific), Middle East & Africa (South Africa, Saudi Arabia, U.A.E., and Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and Rest of South & Central America).

The report evaluates market dynamics during the forecast period, i.e., drivers, restraints, opportunities, and future trends in the global wearable market injectors market. The report also provides an exhaustive PEST analysis for all five regions: North America, Europe, APAC, MEA, and South & Central America, after evaluating political, economic, social, and technological factors affecting the market in these regions.

Market Driver:

Factors such as the increasing prevalence of chronic diseases, rising technological advancements and design development are driving the growth of the global wearable injector market. Also, the limitations of conventional drug delivery systems is also driving market. Wearable injectors are subcutaneous drug delivery systems that adhere to the body and administer larger volumes (more than 2 mL) of the drug over an extended period. With wearable injectors, needle stick injuries can be avoided that are caused during parenteral drug administration using injections. Large-volume wearable injectors are rapidly gaining prominence in the market due to their capabilities to deliver a high volume of viscous formulations. The administration of pharmaceuticals via intravenous (IV) infusion is expensive in healthcare settings. Self-administration of subcutaneous injections is expected to save 30–70% of costs.

Moreover, administration through conventional methods poses risks such as inaccurate dosage and needle stick injuries. Therefore, wearable injectors make them desirable for treating chronic diseases where long-term treatment is necessary. Chronic diseases, such as diabetes, cardiovascular disorders, neurological disorders, autoimmune disorders, and various types of cancer, are the leading causes of death and disability worldwide. Per the data published by the Centers for Disease Control and Prevention (CDC) in 2023, 6 out of 10 people in the U.S. suffered from at least one chronic disease, such as heart disease and stroke, cancer, or diabetes. According to the International Diabetes Federation (IDF), 537 million people worldwide, aged 20–79, had diabetes in 2021, and the number is estimated to rise to 783 million by 2045. In diabetes patients, exogenous Insulin is usually administered through a subcutaneous route of administration for diabetes management. The wearable injector is an ideal drug delivery method for painless and accurate insulin dosages. Hence, the adoption of wearable injectors is likely to increase, which, in turn, propels the wearable injectors market growth. However, the lack of adoption of wearable injection as a drug delivery system in emerging countries is restraining the market’s growth.

Segmental Analysis:

The wearable injectors market is bifurcated based on the type into on-body and off-body injectors. The on-body injectors segment accounted for the largest wearable injectors market share in 2019. On-body injectors offer benefits like comfort, water resistance, flexible dosing, and automatic warming of refrigerated drugs and are easy to use. These benefits have increased the demand for on-body injectors. In comparison, the off-body injectors segment is growing fast at a CAGR of 12.3% during the forecast period.

Based on application, the wearable injectors market is segmented into oncology, diabetes, autoimmune diseases, cardiovascular disease, and other applications. The oncology segment held the largest wearable injectors market share in 2019. However, the autoimmune disease segment is estimated to register the highest CAGR in the wearable injectors market during the forecast period. Cancer includes various diseases resulting from the unregulated growth of malignant cells. Cancer is one of the significant health problems with a high mortality rate. Wearable injectors are witnessing a considerable increase in their adoption across the healthcare industry due to their benefits, such as reducing disease progression and pain in cancer patients. The on-body injector is placed on the stomach or the back of the arm. A healthcare professional applies it on the last day of the chemotherapy cycle. Therefore, the rise in the prevalence of cancer is one of the primary drivers for the segment's growth. Based on end-user, the market is broken down into homecare settings, hospitals and clinics, and others. The homecare setting segment led the market in 2019 with the highest market share and is expected to retain its highest share during the forecast period. The home care segment is anticipated to dominate due to the growing inclination for self-administration of medicine and the rising need to decrease healthcare costs. The hospital serves a significant role by providing extensive medical services to patients suffering from various diseases. This increased the adoption of drug delivery systems in hospitals and clinics. This and the growing number of hospital admissions will drive the segment's growth. Growth of hospitals and clinics is projected to be 12.2% during the forecast period. The other end-users of wearable injectors worldwide are ambulatory surgical centers, nursing homes, diagnostics centers, and other medical centers using drug delivery devices.

Regional Analysis:

The report provides a detailed overview of the global wearable injectors market, including qualitative and quantitative information. It provides an overview and forecast of the global wearable injectors market estimating from 2019 to 2027 concerning five major regions: North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA), and South & Central America. The wearable injectors market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally and the current trend and opportunities prevailing in the region.

North America is the dominating region in the wearable injectors market. The North American wearable injectors market is expected to grow at a CAGR of 11.9% during the forecast period. The North American wearable injectors market is analyzed based on the US, Canada, and Mexico regions. The rising prevalence of chronic diseases like cancer, diabetes, oncology, cardiovascular diseases, and others characterizes the growth of the North American market. Along with the development of innovative products and the presence of key market players in the region. In addition, the increasing prevalence of diabetes in the U.S. is likely to fuel the wearable injector market growth in the country. In 2021, the National Diabetes Statistics report presented by the Centers for Disease Control and Prevention (CDC) stated that nearly 37.3 million people in the U.S. had diabetes, of which type 1 diabetes patients are ~1.45 million. The growing prevalence of cancer is expected to raise the demand for wearable injectors in North America. For instance, as per the American Cancer Society, ~1.9 million new cancer cases were detected in 2022. Breast cancer, prostate cancer, and melanoma cancer are among the common types of cancer in the country. In addition, technological advancements for treating diseases are likely to be a major growth stimulator for the wearable injectors market in North America. For instance, In June 2018, Tandem Diabetes Care, Inc., a manufacturer of touchscreen insulin pumps in the U.S., received U.S. Food and Drug Administration (FDA) approval of the t:slim X2 Insulin Pump. This pump has Basal-IQ technology with predictive low glucose, suspend (PLGS) feature helpful in reducing the frequency and duration of low glucose events (hypoglycemia).

Asia Pacific is the fastest-growing wearable injectors market among all the regions. The CAGR of the Asia-Pacific region during the projected forecast is 12.4%. China, India, and Japan are three major contributors to the market's growth. These countries drives growth by the rise in the geriatric population, the increasing prevalence of chronic diseases, and research in the field of wearable medical devices. Additionally, supportive government initiatives and investments by international market players fuel the growth of the market.

Key Player Analysis:

The report covers key global wearable injectors market developments as organic and inorganic growth strategies. Global wearable injectors market players are anticipated to have lucrative growth opportunities. The wearable injectors market analysis consists of the players such as Amgen, Inc., Medtronic, BD, Insulet Corporation, Gerresheimer AG (Sensile Medical), West Pharmaceutical Services, Inc., Ypsomed AG, Tandem Diabetes Care, Inc., CeQur SA, Debiotech S.A, Zealand Pharma A/S, Elcam Medical. Due to their diversified product portfolio, Amgen Inc and Medtronic are the top two players in the wearable injectors market.

Wearable Injectors Market Report Scope

Report Attribute Details
Market size in 2019 US$ 5.79 Billion
Market Size by 2027 US$ 13.88 Billion
Global CAGR (2019 - 2027) 11.6%
Historical Data 2017-2018
Forecast period 2020-2027
Segments Covered By Type
  • On-Body Injectors
  • Off-Body Injectors
By Application
  • Diabetes
  • Oncology
  • Cardiovascular Disease
  • Autoimmune Disease
  • Other Applications
By End User
  • Hospitals and Clinics
  • Homecare Settings
  • Other End Users
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Amgen, Inc.
  • Medtronic
  • BD
  • Insulet Corporation
  • Gerresheimer AG (Sensile Medical)
  • West Pharmaceutical Services, Inc.
  • Ypsomed AG,
  • Tandem Diabetes Care, Inc.
  • Cequr SA
    • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

    Recent Developments:

    Companies in the wearable injectors market highly adopt inorganic and organic strategies such as mergers and acquisitions. A few recent key market developments are listed below:

    1. In November 2022, Medtronic launched the Medtronic Extended infusion set, the first and only labeled for up to 7-day wear. This innovation is estimated to save Insulin up to 25% due to a reduced number of infusion set and reservoir changes and plastic waste reduction of up to 50%.
    2. In December 2020, B.D. Libertas Wearable Injector cleared 52-subject human clinical trial. The injector is a subcutaneous drug delivery system designed to require no patient assembly and deliver biologics with viscosities up to 50 cP in 2-5 mL and 5-10 mL configurations.
    3. In April 2020, Zealand Pharma A/S acquired all Valeritas Holdings, Inc. assets for a cash purchase of about US$ 23 million. This acquisition has helped to extend its business from its existing pharmaceutical business.
    4. In January 2020, Tandem Diabetes Care launched the t:slim X2 Insulin Pump with Control-IQ Technology in the U.S.
    5. In September 2019, Insulet Corporation received clearance from the U.S. FDA for its Alternate Controller Enabled Infusion Pump. This approval has allowed the company to market its Omni pod DASH Insulin Management System as an integrated insulin pump.
    Report Coverage
    Report Coverage

    Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

    Segment Covered
    Segment Covered

    This text is related
    to segments covered.

    Regional Scope
    Regional Scope

    North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

    Country Scope
    Country Scope

    This text is related
    to country scope.

    Frequently Asked Questions

    What are the wearable injectors?

    Wearable injectors are drug delivery devices that adhere to the body to deliver larger volumes of drugs subcutaneously. Several pharmaceutical and medical device companies have developed wearable injectors. Wearable injectors consist of a reservoir for the medication, a cannula for delivery to the tissue, adhesive to fix the device to the patient’s skin, and a drive system to deliver the appropriate drug volume.

    What are the driving factors for the wearable injectors market across the globe?

    The global wearable injectors market is being driven by factors such as the increasing chronic diseases prevalence, technological advancements & design development, and conventional drug delivery system limitations. Furthermore, increasing demand for biologics is likely to offer significant opportunities for the growth of the global wearable injectors market.

    What are the restraining factors for the wearable injectors market across the globe?

    The lack of adoption in emerging countries is the significant factor that will impede the wearable injectors market growth. The development of biopharmaceuticals and complex chemicals, along with novel approaches to drug delivery, is driven owing to a vast portion of the population suffering from chronic conditions across the world. In developed countries, insurance coverage helps in the adoption of innovative technologies, such as wearable injector devices, whereas, in developing countries, a large portion of the population is not able to afford necessary treatment drugs for chronic diseases.

    The List of Companies - Wearable Injectors Market

    1. Amgen, Inc.
    2. Medtronic
    3. BD
    4. Insulet Corporation
    5. Gerresheimer AG (Sensile Medical)
    6. West Pharmaceutical Services, Inc.
    7. Ypsomed AG,
    8. Tandem Diabetes Care, Inc.
    9. Cequr SA
    10. Debiotech S.A
    11. E3D Elcam Drug Delivery Devices
    12. Zealand Pharma A/S (Valeritas, Inc.)

    The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

    1. Data Collection and Secondary Research:

    As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

    Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

    1. Primary Research:

    The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

    For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

    A typical research interview fulfils the following functions:

    • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
    • Validates and strengthens in-house secondary research findings
    • Develops the analysis team’s expertise and market understanding

    Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

    • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
    • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

    Below is the breakup of our primary respondents by company, designation, and region:

    Research Methodology

    Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

    1. Data Analysis:

    Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

    • 3.1 Macro-Economic Factor Analysis:

    We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

    • 3.2 Country Level Data:

    Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

    • 3.3 Company Profile:

    The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

    • 3.4 Developing Base Number:

    Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

    1. Data Triangulation and Final Review:

    The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

    We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

    We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

    Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

    Trends and growth analysis reports related to Global Archive - Wearable Injectors Market